Scarica l'app Stockscreener
0.5831
1.50%
-0.0089
Dopo l'orario di chiusura:
.57
-0.0131
-2.25%
Precedente Chiudi:
$0.592
Aprire:
$0.59
Volume 24 ore:
652.47K
Relative Volume:
0.93
Capitalizzazione di mercato:
$50.37M
Reddito:
$2.24M
Utile/perdita netta:
$-136.67M
Rapporto P/E:
-0.2546
EPS:
-2.29
Flusso di cassa netto:
$-102.08M
1 W Prestazione:
+1.00%
1M Prestazione:
+17.09%
6M Prestazione:
+7.66%
1 anno Prestazione:
-49.30%
Intervallo 1D:
$0.5756
$0.60
Intervallo di 1 settimana:
$0.552
$0.63
Portata 52W:
$0.3418
$1.83
Century Therapeutics Inc Stock (IPSC) Company Profile
Nome
Century Therapeutics Inc
Settore
Industria
Telefono
215-981-4000
Indirizzo
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Confronta IPSC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.5831 | 51.14M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Iniziato | Rodman & Renshaw | Buy |
| 2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-27 | Iniziato | Chardan Capital Markets | Buy |
| 2022-10-31 | Iniziato | Guggenheim | Buy |
| 2022-10-10 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-12 | Iniziato | William Blair | Mkt Perform |
| 2021-07-13 | Iniziato | BofA Securities | Buy |
| 2021-07-13 | Iniziato | JP Morgan | Overweight |
| 2021-07-13 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Century Therapeutics Inc Borsa (IPSC) Ultime notizie
How Century Therapeutics Inc. stock compares to industry benchmarksPortfolio Return Summary & Short-Term Trading Alerts - newser.com
Century Therapeutics Inc. stock trendline breakdownTrade Ideas & Real-Time Chart Breakout Alerts - newser.com
Is Century Therapeutics Inc a good long term investmentStop Loss Placement Tips & Small Entry Portfolio - earlytimes.in
What does recent volatility data suggest for Century Therapeutics Inc.July 2025 Volume & Community Verified Trade Signals - newser.com
What Fibonacci levels say about Century Therapeutics Inc. reboundJuly 2025 Chart Watch & Precise Entry and Exit Recommendations - newser.com
Can volume confirm reversal in Century Therapeutics Inc.July 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - newser.com
Visual analytics tools that track Century Therapeutics Inc. performanceGap Up & Weekly Setup with High ROI Potential - newser.com
Published on: 2025-11-01 08:35:05 - newser.com
Does Century Therapeutics Inc. show high probability of reboundMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com
Custom strategy builders for tracking Century Therapeutics Inc.2025 Macro Impact & Free Safe Entry Trade Signal Reports - newser.com
Century Therapeutics Inc. stock trend outlook and recovery pathTrade Exit Report & AI Powered Market Trend Analysis - newser.com
Century Therapeutics Inc. stock volume spike explained2025 Market WrapUp & Safe Capital Preservation Plans - newser.com
How to manage a losing position in Century Therapeutics Inc.Rate Hike & Verified Chart Pattern Signals - newser.com
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Decreases By 74.9% - MarketBeat
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is Century Therapeutics Inc. stock overvalued by current metrics2025 Fundamental Recap & Risk Controlled Daily Plans - fcp.pa.gov.br
Century Therapeutics Inc. stock momentum explainedMarket Performance Report & AI Powered Market Entry Strategies - newser.com
Is Century Therapeutics Inc. stock a top pick in earnings season2025 Macro Impact & Short-Term High Return Ideas - Fundação Cultural do Pará
Century Therapeutics’ CALiPSO-1 Study: A Promising Step in Autoimmune Disease Treatment - TipRanks
Century Therapeutics’ Long-Term Follow-Up Study: Key Insights for Investors - TipRanks
How sustainable is Century Therapeutics Inc. stock dividend payoutInsider Buying & AI Forecast for Swing Trade Picks - fcp.pa.gov.br
Century Therapeutics Inc Azioni (IPSC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):